BiotechTube
Home/ADC Therapeutics/Victor Sandor
VS

Victor Sandor

Non-Executive Director, Board of Directors

ADC Therapeutics

Therapeutic Areas

OncologyHematology

ADC Therapeutics Pipeline

DrugIndicationPhase
ZYNLONTA® (loncastuximab tesirine-lpyl)Relapsed/Refractory DLBCLApproved
ZYNLONTA® combinationsEarlier lines of DLBCLPhase 3
ZYNLONTA®Indolent Non-Hodgkin LymphomasPhase 2
ADCT-601Advanced Solid TumorsPhase 1/2
ADCT-901Advanced Solid TumorsPhase 1

Leadership Team at ADC Therapeutics

AM
Ameet Mallik
Chief Executive Officer
PG
Peter Graham
Chief Legal Officer
DE
David Ege
Chief Technical Officer
JC
Joseph Camardo
Chief Medical Officer
KP
Kimberly Pope
Senior Vice President, Human Resources
View full ADC Therapeutics profile